<DOC>
	<DOCNO>NCT00349011</DOCNO>
	<brief_summary>The purpose study determine effect personalize menopausal therapy risk assessment genetic counseling intervention knowledge , risk perception , decision-making healthy woman increase risk breast cancer .</brief_summary>
	<brief_title>Genetic Counseling Menopausal Therapy Decision-Making Women Increased Risk Breast Cancer</brief_title>
	<detailed_description>Women family history breast cancer several menopausal therapy option , include tamoxifen , hormone therapy , alternative medication , treatment . This complex decision base woman â€™ risk develop breast cancer , menopausal symptom , preference , risk condition . Current model use menopausal therapy counsel include pedigree analysis , personalize risk assessment genetic testing process . The purpose multi-center study determine effect personalize risk assessment genetic counseling intervention knowledge , risk perception , decision-making group healthy woman first-degree relative breast cancer . Intervention participant give personalized risk assessment breast cancer , heart disease , osteoporosis , uterine cancer base family history personal health data .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>least one first degree relative breast cancer age 40 old currently take menopausal therapy previous cancer diagnosis ( except basal cell carcinoma ) previous diagnosis atypical hyperplasia previous diagnosis lobular carcinoma situ ( LCIS ) know carrier BRCA1 BRCA2 mutation personal history heart disease &gt; 10 % risk carry BRCA1 BRCA2 mutation</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>menopause</keyword>
	<keyword>genetic counseling</keyword>
	<keyword>breast cancer</keyword>
	<keyword>tamoxifen</keyword>
	<keyword>chemoprevention</keyword>
</DOC>